Weight of active pharmaceutical ingredients manufactured or used that are suspected of AMR by type

Unit

i
: Metric tonnes (t)

Indicator

i
: Pollutants released to environment

Metric type

i
: Pressure

Framework alignment notes

i
BP.C2.3
Refer to AMR's Shared Goals for alignment to metric
WHO Guidance
Refer to EFPIA's Clear Steps Toward a Greener Future - Pharmaceutical Sector’s Environmental Sustainability Statement (10.06.24) for alignment to metric
T7

Target example

Metric is highly sensitive and does not support development of strategic targets. As this metric is not expected to be prioritized, a draft target has not been developed at this time

Target Source: No metric drafted at this time

Sector

i
Pharmaceutical

Value chain stage

i
Raw Materials Manufacturing End of Life

Metric assessment

i

Relevance: Medium

Feasibility: Medium

Related actions

Reduce waste to landfill by introducing a waste hierarchy into management systems

Reduce waste to landfill by introducing a waste hierarchy into management systems

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce water and soil pollution risk from APIs, especially antibiotics, harmful chemicals and other relevant substances from manufacturing sites

Reduce water and soil pollution risk from APIs, especially antibiotics, harmful chemicals and other relevant substances from manufacturing sites

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce air, water and soil pollution (including non-GHG emissions) from agriculture-related pharmaceutical manufacturing feedstocks by engaging with suppliers and encouraging the adoption of less polluting methods in alignment with a Science Based Targets Network (SBTN) Landscape Engagement Target

Reduce air, water and soil pollution (including non-GHG emissions) from agriculture-related pharmaceutical manufacturing feedstocks by engaging with suppliers and encouraging the adoption of less polluting methods in alignment with a Science Based Targets Network (SBTN) Landscape Engagement Target

Description

Value chain stage

Raw Materials

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce APIs (including antibiotics) in the environment by designing more biodegradable pharmaceuticals that decompose faster in the environment after excretion

Reduce APIs (including antibiotics) in the environment by designing more biodegradable pharmaceuticals that decompose faster in the environment after excretion

Description

Value chain stage

End of Life

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce APIs (including antibiotics) in the environment by investing in and supporting the development of technologies that enhance the removal of pharmaceutical residues from wastewater

Reduce APIs (including antibiotics) in the environment by investing in and supporting the development of technologies that enhance the removal of pharmaceutical residues from wastewater

Description

Value chain stage

End of Life

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce APIs (including antibiotics) in the environment through public education and information campaigns encouraging correct medicine disposal

Reduce APIs (including antibiotics) in the environment through public education and information campaigns encouraging correct medicine disposal

Description

Value chain stage

End of Life

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Carefully consider nature-related impacts, dependencies, risks and opportunities when establishing new operations, taking water risks and proximity to areas of significant biodiversity value into account. Embed biodiversity and water risk assessment criteria into the decision-making process when selecting new sites or expansions and prioritize action according to conservation hierarchy in locations that meet the criteria

Carefully consider nature-related impacts, dependencies, risks and opportunities when establishing new operations, taking water risks and proximity to areas of significant biodiversity value into account. Embed biodiversity and water risk assessment criteria into the decision-making process when selecting new sites or expansions and prioritize action according to conservation hierarchy in locations that meet the criteria

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon